Advances in molecular biology, biomarkers, and digital technologies are driving the transition towards more precise and individualized cardiovascular care.
Cardiovascular medicine continues to evolve rapidly through advances in molecular biology, biomarkers, digital technologies, and interventional strategies. Recent contributions highlight progress in arrhythmia management, artificial intelligence-assisted diagnostics, metabolic and inflammatory risk stratification, and the understanding of rare cardiomyopathies. These developments illustrate the transition towards more precise and individualised cardiovascular care while raising new clinical and ethical challenges. Integrating technological innovation with clinical expertise remains essential to ensure that advances translate into improved patient outcomes.
Lancellotti et al. (2026) conducted a review in Cardiovascular disease. Advances in molecular biology, biomarkers, and digital technologies are driving the transition towards more precise and individualized cardiovascular care.